A C Nathwani

533 total citations
9 papers, 425 citations indexed

About

A C Nathwani is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, A C Nathwani has authored 9 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in A C Nathwani's work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (3 papers). A C Nathwani is often cited by papers focused on Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and RNA Interference and Gene Delivery (3 papers). A C Nathwani collaborates with scholars based in United States, United Kingdom and Switzerland. A C Nathwani's co-authors include Andrew M. Davidoff, Arthur W. Nienhuis, Yanaí Durán, Susie E. Barker, Jenny McIntosh, Robin R. Ali, M Natkunarajah, Alexander J. Smith, Katherine A. High and Edward G. D. Tuddenham and has published in prestigious journals such as Gene Therapy, Vox Sanguinis and Haemophilia.

In The Last Decade

A C Nathwani

9 papers receiving 412 citations

Peers

Countries citing papers authored by A C Nathwani

Since Specialization

Citations

This map shows the geographic impact of A C Nathwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A C Nathwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A C Nathwani more than expected).

Fields of papers citing papers by A C Nathwani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A C Nathwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A C Nathwani. The network helps show where A C Nathwani may publish in the future.

Co-authorship network of co-authors of A C Nathwani

This figure shows the co-authorship network connecting the top 25 collaborators of A C Nathwani. A scholar is included among the top collaborators of A C Nathwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A C Nathwani. A C Nathwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Current status of haemophilia gene therapy 2014 ·Haemophilia ·Katherine A. High, A C Nathwani, H. Trent Spencer, David Lillicrap	53
2	Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine 2011 ·Gene Therapy ·J. McIntosh, Melanie Cochrane, Stephen Cobbold, Herman Waldmann, (unknown), Andrew M. Davidoff, A C Nathwani	56
3	Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells. 2010 ·PubMed ·Regan F. Williams, Thomas L. Sims, Lorraine Tracey, (unknown), Catherine Y. Ng, Helen Poppleton, A C Nathwani, Andrew M. Davidoff	16
4	Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8 2007 ·Gene Therapy ·M Natkunarajah, (unknown), Jenny McIntosh, Yanaí Durán, Susie E. Barker, Alexander J. Smith, A C Nathwani, Robin R. Ali	114
5	Antitumor efficacy of AAV-mediated systemic delivery of interferon-β 2005 ·Cancer Gene Therapy ·Christian J. Streck, Paxton V. Dickson, Catherine Y. Ng, (unknown), (unknown), John T. Gray, A C Nathwani, Andrew M. Davidoff	46
6	Current status and prospects for gene therapy 2004 ·Vox Sanguinis ·A C Nathwani, Reuben Benjamin, Arthur W. Nienhuis, Andrew M. Davidoff	17
7	Prospects for gene therapy of haemophilia 2004 ·Haemophilia ·A C Nathwani, Andrew M. Davidoff, Edward G. D. Tuddenham	40
8	Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38− subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV 2000 ·Gene Therapy ·A C Nathwani, Hideki Hanawa, (unknown), (unknown), Elio F. Vanin, Arthur W. Nienhuis	64
9	Adenovirus-mediated expresssion of the murine ecotropic receptor facilitates transduction of human hematopoietic cells with an ecotropic retroviral vector 1999 ·Gene Therapy ·A C Nathwani, Derek A. Persons, Susan C. Stevenson, (unknown), Alan McClelland, Arthur W. Nienhuis, Elio F. Vanin	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact